Specifically, the hedgehog signalling pathway has been targeted for basal cell carcinoma (BCC), while the epidermal growth factor receptor (EGFR) is a key target in cutaneous squamous cell carcinoma (cSCC). This evidence concerns the gene EGFR and basal cell carcinoma.